Nadia Carlesso Selected Research

Nadia Carlesso Research Topics

Disease

5	Inflammation (Inflammations) 07/2014 - 07/2003
4	Leukemia 01/2020 - 04/2011
4	Neoplasms (Cancer) 10/2019 - 07/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 04/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2019 - 04/2011
2	Multiple Myeloma 01/2018 - 03/2016
1	Necrobiotic Disorders (Necrobiosis) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Bone Diseases (Bone Disease) 03/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Sepsis (Septicemia) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Perinatal Death 02/2015
1	Insulin Resistance 08/2014
1	Burns 08/2014
1	Obesity 08/2014
1	Carcinogenesis 07/2014
1	Virus Diseases (Viral Diseases) 02/2012
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2010
1	Bone Marrow Failure Disorders 07/2010

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2014
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	PNC-27IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Histones (Histone)IBA 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	CopperIBA 01/2018
1	Sirtuin 1IBA 01/2018
1	daratumumabIBA 01/2018
1	Notch ReceptorsIBA 03/2016
1	CeramidesIBA 01/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2016
1	AcidsIBA 01/2016
1	EnzymesIBA 01/2016
1	SmokeIBA 01/2016
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Toll-Like Receptor 4IBA 01/2016
1	CateninsIBA 02/2015
1	Blood Glucose (Blood Sugar)IBA 08/2014
1	Glucose (Dextrose)FDA LinkGeneric 08/2014
1	LipidsIBA 08/2014
1	Interleukin-5 (Interleukin 5)IBA 09/2012
1	CytokinesIBA 09/2012
1	Interleukin-4 (Interleukin 4)IBA 09/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2012
1	Immunoglobulin E (IgE)IBA 09/2012
1	OvalbuminIBA 09/2012
1	guanosine 5'-monophosphorothioateIBA 02/2012
1	Ribosomal Proteins (Ribosomal Protein)IBA 04/2011
1	TOR Serine-Threonine KinasesIBA 04/2011
1	Sirolimus (Rapamycin)FDA Link 04/2011
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 04/2011
1	Cyclin-Dependent Kinase Inhibitor p27IBA 04/2011
1	temsirolimus FDA Link 04/2011
1	Alkaline PhosphataseIBA 10/2010
1	CalciumIBA 10/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2007
1	PTX3 proteinIBA 06/2007
1	Scavenger Receptors (Scavenger Receptor)IBA 06/2007
1	Leukotriene B4IBA 07/2003
1	C-terminal binding proteinIBA 07/2003

Therapy/Procedure

4	Therapeutics 10/2019 - 07/2010
1	Drug Therapy (Chemotherapy) 10/2019